Topics

Companies Related to "Hyperuricemia Pipeline Drugs Companies 2019 Report Updated 08042019" [Most Relevant Company Matches] RSS

20:14 EST 15th December 2019 | BioPortfolio

Here are the most relevant search results for "Hyperuricemia Pipeline Drugs Companies 2019 Report Updated 08042019" found in our extensive corporate database of over 50,000 company records.

Showing "Hyperuricemia Pipeline Drugs Companies 2019 Report Updated 08042019" Companies 1–25 of 3,700+

Relevant

Phoenix Pharmacologics Inc.,

Phoenix Pharmacologics Inc., with its principal headquarterslocated in, San Diego, California, is a privately-held emerging biopharmaceutical company that specializes in developing drugs to treat cancer and related disorders. Two of its protein drugs are in late stage clinical trials: ADI-PEG 20 for the treatment of hepatocellular carcinoma and metastatic melanoma,and Uricase-PEG 20 for the treatm...


I AM ALS

Founded in 2019 by Brian Wallach and his wife, Sandra Abrevaya, I AM ALS was born out of their desire to change the future for Brian and the thousands of other ALS patients in the world. I AM ALS brings together patients, advocates, organizations and scientists to deliver critical and innovative resources for patients, empower and mobilize patients and the...

HealthLeaders-InterStudy

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly and covering 35 states plus the District of Columbia, each report provides a detailed look at:


BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH Patent News, summaries of recently issued US patents, descriptions of biotechnology available for license, and recent commentary and reviews by biotechology legal professionals. BIOTECH Patent Report...

Xenetic Biosciences plc

Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas. Xenetic are also a...

XLerateHealth

XLerateHealth is an enterprise-focused early-stage healthcare accelerator that helps companies build out their commercialization strategies. Through its flagship 12-week bootcamp, XLH connects selected startups with domain experts, mentors, and coaches who have the expertise to help the entrepreneurs think through all aspects of commercialization. The organization has been in operation since 2013...

BioTech Stock Report

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases, beyond the momentum-driven stock analysts, and past the hype of mainstream stock-touters. The BioTech Stock Report gets to the core of what makes biotechnology companies tick: Science and Innovation....

Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. Spectrum currently markets six hematology/oncology drugs and has an advanced stage pipeline that has the potential to transform the company. Spectrum's strong track record for in-l...

Human Genome Sciences

The mission of Human Genome Sciences is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. Clinical Development Pipeline The HGS clinical development pipeline includes drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. The Company’s primary focu...

Threshold Pharmaceuticals, Inc.

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effe...

Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company’s lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with ...

Delaware North Companies

Delaware North Companies is one of the world's leading hospitality and food service providers. Its family of companies includes Delaware North Companies Parks & Resorts, Delaware North Companies Gaming & Entertainment, Delaware North Companies Travel Hospitality Services, Delaware North Companies Sportservice, Delaware North Companies International and Delaware North Companies Boston, owner of TD ...

MWW Group

MWW Group is one of the nation's top ten public relations agencies and is known for its results-driven approach to public relations and "Aim High. . . and Deliver" commitment to client service. For the past four years, MWW Group has been honored with the #1 ranking in the Holmes Report agency client satisfaction survey. MWW Group achieved top rankings in the categories of account leadership, stren...

BioInvent

BioInvent International AB, listed on the NASDAQ OMX Stockholm (BINV), is a research-based pharmaceutical company that focuses on developing antibody drugs. The Company's pipeline currently includes three product candidates for the treatment of cancer. The Company has signed various strategic alliances to strengthen the product pipeline and increase the li...

Ironwood Pharmaceuticals, Inc. 

Ironwood Pharmaceuticals (NASDAQ:IRWD) is a commercial biotechnology company focused on creating medicines that make a difference for patients, building value for our fellow shareholders, and empowering our passionate team. We are commercializing two innovative primary care products: linaclotide, the U.S. branded prescription market leader for adults with ...

Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of therapeutics based on Metabolic Targeting, a powerful scientific approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than convention...

Bosnalijek

Bosnalijek, Pharmaceutical and Chemical Industry, has been in the business of drug manufacturing and marketing for 55 years. The company was established in Sarajevo in 1951. Today, Bosnalijek is a joint stock company and one of the most stable and successful companies in Bosnia and Herzegovina. The production pipeline of Bosnalijek consists of: ethical drugs, drugs for self-medication, disinfectin...

Matan Companies

Headquartered in Frederick Maryland for over 30 years, Matan Companies is one of the regions premier commercial real estate and development firms. Matan's primary geographic focus is Frederick, Maryland and the I-270 Corridor. Matan's current portfolio consists of over 3.2 million square feet in 30 buildings with an additional 3 million square feet in the development pipeline.

Ironwood Pharmaceuticals, Inc. & Astellas Pharma Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is a commercial biotechnology company focused on creating medicines that make a difference for patients, building value for our fellow shareholders, and empowering our passionate team. We are commercializing two innovative primary care products: linaclotide, the U.S. branded prescription market leader for adults with...

Dental Products Report

Dental Products Report aims to provide dentists with comprehensive, accurate and unbiased information across the spectrum of specialties. In consultation with forward-looking clinicians and manufacturers, DPR supports dentists as they apply new products and technologies to patient care. DPR provides readers with quality editorial content such as peer revie...

Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology. The Company’s strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. The Company markets two oncol...

Santaris Pharma A/S

Santaris Pharma is a science-based product-driven biopharmaceutical company focused on oncology. Our mission is to discover, develop and commercialise new and better drugs drugs for the treatment of cancer.We seek to fulfil this mission through an integrated business strategy comprising:Rapid development of own products based on our pioneering RNA antagonist drug platformStructuring of corporate p...

Cylene Pharmaceuticals

Cylene Pharmaceuticals is a privately-held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening cancers. Cylene's pipeline is led by CX-3543, a Quadruplex Inhibitor in Phase 1 clinical development. CX-3543 and other molecules in the pipeline originate from the company's proprietary drug discovery platf...

Medscape, LLC

Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.Most specialty sites are organized consistently so you'll know where to find your favorite features as you move from specialty to specialty. Ea...

Endocyte, Inc.

Endocyte is a privately held biotechnology company with headquarters in the Purdue Research Park of West Lafayette, IN. Based on the applications of Endocyte’s advanced proprietary guided drug technology, the company is working to develop new drugs and diagnostic agents to treat many types of cancer and other serious diseases. The guided drug platform...


More From BioPortfolio on "Hyperuricemia Pipeline Drugs Companies 2019 Report Updated 08042019"

Quick Search

Corporate Database Quicklinks